Clicky

PowerShares Dynamic Biotech & Genome(PBE)

Description: The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.


Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Invesco Powershares Genetic Engineering Inter 10 Index Genome

Home Page: www.invesco.com/static/us/productdetail?productId=PBE&productType=ETF

PBE Technical Analysis

Exchange: NYSE ARCA

Country: US

Currency: US Dollar ($)

Category: Health

Asset Allocation
Asset Class Long % Short % Net Assets
Stock US 99.92 0.00 99.92
Cash 0.08 0.00 0.08
Sector Weights
Sector Equity % Relative to Category
Healthcare 100.00 99.57
World Regions
Region Equity % Relative to Category
North America 100.00 92.60
Japan 0.00 0.54
Australasia 0.00 0.11
Asia Emerging 0.00 0.82
United Kingdom 0.00 1.65
Europe Developed 0.00 4.28
Africa/Middle East 0.00 0.02
Back to stocks